Arlington Trust’s Hamilton Lane HLNE Stock Holding History

Arlington Trust’s Portfolio HLNE Stock Details HLNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$426	–	629
2025 Q2	$426	Buy	+3	New	+$452	﹤0.01%	656

Other funds holding HLNE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arlington Trust's HLNE Position: Q3 2025 in Review

Arlington Trust sold out of Hamilton Lane (HLNE) in Q3 2025, closing a stake of 3 shares — an estimated $426 sold.

Arlington Trust first reported a position in HLNE in Q2 2025 and held it in 1 quarter. The position peaked at $426 in Q2 2025. 382 funds tracked by Wall St. Rank hold HLNE as of Q3 2025.

Arlington Trust reported no remaining Hamilton Lane position as of Q3 2025 after selling out during the quarter.
Arlington Trust sold 3 Hamilton Lane shares in Q3 2025, an estimated $426.
Arlington Trust first reported a position in Hamilton Lane in Q2 2025 and held it in 1 quarter.
Arlington Trust's Hamilton Lane position peaked at $426 in Q2 2025.
382 funds tracked by Wall St. Rank held Hamilton Lane as of Q3 2025.

Based on Arlington Trust's 13F filing for Q3 2025, filed 28 Oct 2025.